Literature DB >> 12667276

Update on pediatric acute respiratory distress syndrome.

Michael R Anderson1.   

Abstract

Pediatric acute respiratory distress syndrome (ARDS) remains an important challenge for the intensive care clinician. ARDS, which can result from either direct lung injury or from a "downstream" inflammatory process, is manifested by profound hypoxemia and respiratory failure. The care of pediatric ARDS is based on a meticulous, multidisciplinary, intensive care team approach. This review discusses the changing definition of ARDS and available intensive care treatment modalities, including newer lung-protective mechanical ventilation strategies and adjunct therapies. The prognosis of children suffering pediatric ARDS is examined with a look toward areas of potential future intervention in this often deadly disease. Copyright 2003 Daedalus Enterprises

Entities:  

Mesh:

Year:  2003        PMID: 12667276

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  5 in total

Review 1.  Hypoxia signaling during acute lung injury.

Authors:  Christine U Vohwinkel; Sandra Hoegl; Holger K Eltzschig
Journal:  J Appl Physiol (1985)       Date:  2015-05-14

Review 2.  Aerosolized prostacyclins for acute respiratory distress syndrome (ARDS).

Authors:  Arash Afshari; Anders Bastholm Bille; Mikkel Allingstrup
Journal:  Cochrane Database Syst Rev       Date:  2017-07-24

3.  Topical interleukin-8 antibody attracts leukocytes in a piglet lavage model.

Authors:  Tobias Ankermann; Tina Wiemann; Anja Reisner; Marzenna Orlowska-Volk; Heike Köhler; Martin F Krause
Journal:  Intensive Care Med       Date:  2004-10-20       Impact factor: 17.440

4.  Risk parameters of fulminant acute respiratory distress syndrome and avian influenza (H5N1) infection in Vietnamese children.

Authors:  Shoji Kawachi; San Thi Luong; Mika Shigematsu; Hiroyuki Furuya; Thuy Thi Bich Phung; Phuc Huu Phan; Hiroyuki Nunoi; Liem Thanh Nguyen; Kazuo Suzuki
Journal:  J Infect Dis       Date:  2009-08-15       Impact factor: 5.226

Review 5.  Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults.

Authors:  Fabienne Gebistorf; Oliver Karam; Jørn Wetterslev; Arash Afshari
Journal:  Cochrane Database Syst Rev       Date:  2016-06-27
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.